Table 2.

Diagnostic values of miR-193b-5p, CEA, and CA15-3 for breast cancer.

Markers	AUC	95% CI	Sensitivity
			90% specificity	95% CI	Cut off
Breast cancer versus normal control
miR-193b-5p	0.762***	0.674-0.851	34.48%	0.225-0.481	1.23
CEA	0.567	0.463-0.672	15.52%	0.073-0.274	3.15
CA15-3	0.552	0.447-0.658	17.91%	0.050-0.233	17.91
miR-193b-5p+CEA	0.773***	0.687-0.860	25.86%	0.153-0.391
miR-193b-5p+CA15-3	0.767***	0.680-0.854	27.59%	0.167-0.409
CEA+CA15-3	0.583	0.489-0.688	17.24%	0.086-0.294
Breast cancer versus benign disease
miR-193b-5p	0.770***	0.677-0.863	60.34%	0.466-0.730	2.49
CEA	0.516	0.395-0.638	11.11%	0.031-0.261	0.86
CA15-3	0.506	0.388-0.624	16.17%	0.086-0.294	16.2
miR-193b-5p+CEA	0.738**	0.638-0.840	34.48%	0.225-0.482
miR-193b-5p+CA15-3	0.760***	0.662-0.859	58.62%	0.449-0.714
CEA+CA15-3	0.525	0.404-0.646	18.97%	0.099-0.314

**P<0.01; ***P <0.001